Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lung Neoplasms 4Glioblastoma 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Brain Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lymphoma, B-Cell 2Gliosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Skin Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1Meningeal Carcinomatosis 1Melanoma 1

Interventions

Magnetic Resonance Spectroscopy 4Temozolomide 3Radiotherapy 2vocimagene amiretrorepvec 1gallium Ga 68 dotatate 1cabazitaxel 1Radiation 1Proton Magnetic Resonance Spectroscopy 1Procarbazine 1OKN 007 1Nivolumab 1Magnetic Resonance Imaging 1Isotretinoin 1Irinotecan 1Gadolinium DTPA 1Filgrastim 1Equipment and Supplies 1DNA 1Carboplatin 1Biopsy 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Oligodendroglioma × Radiation × Clear all
NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

NRG Oncology

Phase 2/3 Withdrawn
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡